Global Influenza Vaccine Market Research Report 2023

Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.

Highlights

The global Influenza Vaccine market was valued at US$ 7599.8 million in 2022 and is anticipated to reach US$ 10950 million by 2029, witnessing a CAGR of 5.3% during the forecast period 2023-2029.

The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

Global influenza vaccine main players include CSL, GSK, Sanofi Pasteur, AstraZeneca etc.The top 5 account for about 95% of market. North America is the largest market of influenza vaccine, with a share about 45%. As for the types of products, it can be divided into trivalent influenza vaccine and quadrivalent influenza vaccine. The most common product is quadrivalent influenza vaccine, with a share over 90%. In terms of applications, it is widely used in for children (6 months to 3 years) and For adults and children over 3 years. The most application is in adults and children over 3 years, with a share over 80%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Vaccine.

The Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Influenza Vaccine market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Sanofi

CSL

GSK

Viatris

AstraZeneca

Hualan Bio

Changchun Institute of Biological

Sinovac

BCHT

Jiangsu GDK

KM Biologics

Trivalent Influenza Vaccine

Quadrivalent Influenza Vaccine

6 Months to 3 Years

> 3 Years

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

1.1 Product Overview and Scope of Influenza Vaccine

1.2 Influenza Vaccine Segment by Type

1.2.1 Global Influenza Vaccine Market Value Comparison by Type (2023-2029)

1.2.2 Trivalent Influenza Vaccine

1.2.3 Quadrivalent Influenza Vaccine

1.3 Influenza Vaccine Segment by Application

1.3.1 Global Influenza Vaccine Market Value by Application: (2023-2029)

1.3.2 6 Months to 3 Years

1.3.3 > 3 Years

1.4 Global Influenza Vaccine Market Size Estimates and Forecasts

1.4.1 Global Influenza Vaccine Revenue 2018-2029

1.4.2 Global Influenza Vaccine Sales 2018-2029

1.4.3 Global Influenza Vaccine Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)

2.2 Global Influenza Vaccine Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Influenza Vaccine Average Price by Manufacturers (2018-2023)

2.4 Global Influenza Vaccine Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Influenza Vaccine, Product Type & Application

2.7 Influenza Vaccine Market Competitive Situation and Trends

2.7.1 Influenza Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Influenza Vaccine Players Market Share by Revenue

2.7.3 Global Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Influenza Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Influenza Vaccine Global Influenza Vaccine Sales by Region: 2018-2029

3.2.1 Global Influenza Vaccine Sales by Region: 2018-2023

3.2.2 Global Influenza Vaccine Sales by Region: 2024-2029

3.3 Global Influenza Vaccine Global Influenza Vaccine Revenue by Region: 2018-2029

3.3.1 Global Influenza Vaccine Revenue by Region: 2018-2023

3.3.2 Global Influenza Vaccine Revenue by Region: 2024-2029

3.4 North America Influenza Vaccine Market Facts & Figures by Country

3.4.1 North America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Influenza Vaccine Sales by Country (2018-2029)

3.4.3 North America Influenza Vaccine Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Influenza Vaccine Market Facts & Figures by Country

3.5.1 Europe Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Influenza Vaccine Sales by Country (2018-2029)

3.5.3 Europe Influenza Vaccine Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Influenza Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Influenza Vaccine Sales by Country (2018-2029)

3.6.3 Asia Pacific Influenza Vaccine Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Influenza Vaccine Market Facts & Figures by Country

3.7.1 Latin America Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Influenza Vaccine Sales by Country (2018-2029)

3.7.3 Latin America Influenza Vaccine Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Influenza Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Influenza Vaccine Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Influenza Vaccine Sales by Country (2018-2029)

3.8.3 Middle East and Africa Influenza Vaccine Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Influenza Vaccine Sales by Type (2018-2029)

4.1.1 Global Influenza Vaccine Sales by Type (2018-2023)

4.1.2 Global Influenza Vaccine Sales by Type (2024-2029)

4.1.3 Global Influenza Vaccine Sales Market Share by Type (2018-2029)

4.2 Global Influenza Vaccine Revenue by Type (2018-2029)

4.2.1 Global Influenza Vaccine Revenue by Type (2018-2023)

4.2.2 Global Influenza Vaccine Revenue by Type (2024-2029)

4.2.3 Global Influenza Vaccine Revenue Market Share by Type (2018-2029)

4.3 Global Influenza Vaccine Price by Type (2018-2029)

5.1 Global Influenza Vaccine Sales by Application (2018-2029)

5.1.1 Global Influenza Vaccine Sales by Application (2018-2023)

5.1.2 Global Influenza Vaccine Sales by Application (2024-2029)

5.1.3 Global Influenza Vaccine Sales Market Share by Application (2018-2029)

5.2 Global Influenza Vaccine Revenue by Application (2018-2029)

5.2.1 Global Influenza Vaccine Revenue by Application (2018-2023)

5.2.2 Global Influenza Vaccine Revenue by Application (2024-2029)

5.2.3 Global Influenza Vaccine Revenue Market Share by Application (2018-2029)

5.3 Global Influenza Vaccine Price by Application (2018-2029)

6.1 Sanofi

6.1.1 Sanofi Corporation Information

6.1.2 Sanofi Description and Business Overview

6.1.3 Sanofi Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Sanofi Influenza Vaccine Product Portfolio

6.1.5 Sanofi Recent Developments/Updates

6.2 CSL

6.2.1 CSL Corporation Information

6.2.2 CSL Description and Business Overview

6.2.3 CSL Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.2.4 CSL Influenza Vaccine Product Portfolio

6.2.5 CSL Recent Developments/Updates

6.3 GSK

6.3.1 GSK Corporation Information

6.3.2 GSK Description and Business Overview

6.3.3 GSK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.3.4 GSK Influenza Vaccine Product Portfolio

6.3.5 GSK Recent Developments/Updates

6.4 Viatris

6.4.1 Viatris Corporation Information

6.4.2 Viatris Description and Business Overview

6.4.3 Viatris Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Viatris Influenza Vaccine Product Portfolio

6.4.5 Viatris Recent Developments/Updates

6.5 AstraZeneca

6.5.1 AstraZeneca Corporation Information

6.5.2 AstraZeneca Description and Business Overview

6.5.3 AstraZeneca Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.5.4 AstraZeneca Influenza Vaccine Product Portfolio

6.5.5 AstraZeneca Recent Developments/Updates

6.6 Hualan Bio

6.6.1 Hualan Bio Corporation Information

6.6.2 Hualan Bio Description and Business Overview

6.6.3 Hualan Bio Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.6.4 Hualan Bio Influenza Vaccine Product Portfolio

6.6.5 Hualan Bio Recent Developments/Updates

6.7 Changchun Institute of Biological

6.6.1 Changchun Institute of Biological Corporation Information

6.6.2 Changchun Institute of Biological Description and Business Overview

6.6.3 Changchun Institute of Biological Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Changchun Institute of Biological Influenza Vaccine Product Portfolio

6.7.5 Changchun Institute of Biological Recent Developments/Updates

6.8 Sinovac

6.8.1 Sinovac Corporation Information

6.8.2 Sinovac Description and Business Overview

6.8.3 Sinovac Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Sinovac Influenza Vaccine Product Portfolio

6.8.5 Sinovac Recent Developments/Updates

6.9 BCHT

6.9.1 BCHT Corporation Information

6.9.2 BCHT Description and Business Overview

6.9.3 BCHT Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.9.4 BCHT Influenza Vaccine Product Portfolio

6.9.5 BCHT Recent Developments/Updates

6.10 Jiangsu GDK

6.10.1 Jiangsu GDK Corporation Information

6.10.2 Jiangsu GDK Description and Business Overview

6.10.3 Jiangsu GDK Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.10.4 Jiangsu GDK Influenza Vaccine Product Portfolio

6.10.5 Jiangsu GDK Recent Developments/Updates

6.11 KM Biologics

6.11.1 KM Biologics Corporation Information

6.11.2 KM Biologics Influenza Vaccine Description and Business Overview

6.11.3 KM Biologics Influenza Vaccine Sales, Revenue and Gross Margin (2018-2023)

6.11.4 KM Biologics Influenza Vaccine Product Portfolio

6.11.5 KM Biologics Recent Developments/Updates

7.1 Influenza Vaccine Industry Chain Analysis

7.2 Influenza Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Influenza Vaccine Production Mode & Process

7.4 Influenza Vaccine Sales and Marketing

7.4.1 Influenza Vaccine Sales Channels

7.4.2 Influenza Vaccine Distributors

7.5 Influenza Vaccine Customers

8.1 Influenza Vaccine Industry Trends

8.2 Influenza Vaccine Market Drivers

8.3 Influenza Vaccine Market Challenges

8.4 Influenza Vaccine Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Influenza Vaccine Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Influenza Vaccine Sales (M Doses) of Key Manufacturers (2018-2023)

    Table 5. Global Influenza Vaccine Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Influenza Vaccine Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Influenza Vaccine Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Influenza Vaccine Average Price (USD/Doses) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Influenza Vaccine, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Influenza Vaccine, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Influenza Vaccine, Product Type & Application

    Table 12. Global Key Manufacturers of Influenza Vaccine, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Influenza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza Vaccine as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Influenza Vaccine Sales by Region (2018-2023) & (M Doses)

    Table 18. Global Influenza Vaccine Sales Market Share by Region (2018-2023)

    Table 19. Global Influenza Vaccine Sales by Region (2024-2029) & (M Doses)

    Table 20. Global Influenza Vaccine Sales Market Share by Region (2024-2029)

    Table 21. Global Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Influenza Vaccine Revenue Market Share by Region (2018-2023)

    Table 23. Global Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Influenza Vaccine Revenue Market Share by Region (2024-2029)

    Table 25. North America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Influenza Vaccine Sales by Country (2018-2023) & (M Doses)

    Table 27. North America Influenza Vaccine Sales by Country (2024-2029) & (M Doses)

    Table 28. North America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Influenza Vaccine Sales by Country (2018-2023) & (M Doses)

    Table 32. Europe Influenza Vaccine Sales by Country (2024-2029) & (M Doses)

    Table 33. Europe Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Influenza Vaccine Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Influenza Vaccine Sales by Region (2018-2023) & (M Doses)

    Table 37. Asia Pacific Influenza Vaccine Sales by Region (2024-2029) & (M Doses)

    Table 38. Asia Pacific Influenza Vaccine Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Influenza Vaccine Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Influenza Vaccine Sales by Country (2018-2023) & (M Doses)

    Table 42. Latin America Influenza Vaccine Sales by Country (2024-2029) & (M Doses)

    Table 43. Latin America Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Influenza Vaccine Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Influenza Vaccine Sales by Country (2018-2023) & (M Doses)

    Table 47. Middle East & Africa Influenza Vaccine Sales by Country (2024-2029) & (M Doses)

    Table 48. Middle East & Africa Influenza Vaccine Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Influenza Vaccine Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Influenza Vaccine Sales (M Doses) by Type (2018-2023)

    Table 51. Global Influenza Vaccine Sales (M Doses) by Type (2024-2029)

    Table 52. Global Influenza Vaccine Sales Market Share by Type (2018-2023)

    Table 53. Global Influenza Vaccine Sales Market Share by Type (2024-2029)

    Table 54. Global Influenza Vaccine Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Influenza Vaccine Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Influenza Vaccine Revenue Market Share by Type (2018-2023)

    Table 57. Global Influenza Vaccine Revenue Market Share by Type (2024-2029)

    Table 58. Global Influenza Vaccine Price (USD/Doses) by Type (2018-2023)

    Table 59. Global Influenza Vaccine Price (USD/Doses) by Type (2024-2029)

    Table 60. Global Influenza Vaccine Sales (M Doses) by Application (2018-2023)

    Table 61. Global Influenza Vaccine Sales (M Doses) by Application (2024-2029)

    Table 62. Global Influenza Vaccine Sales Market Share by Application (2018-2023)

    Table 63. Global Influenza Vaccine Sales Market Share by Application (2024-2029)

    Table 64. Global Influenza Vaccine Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Influenza Vaccine Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Influenza Vaccine Revenue Market Share by Application (2018-2023)

    Table 67. Global Influenza Vaccine Revenue Market Share by Application (2024-2029)

    Table 68. Global Influenza Vaccine Price (USD/Doses) by Application (2018-2023)

    Table 69. Global Influenza Vaccine Price (USD/Doses) by Application (2024-2029)

    Table 70. Sanofi Corporation Information

    Table 71. Sanofi Description and Business Overview

    Table 72. Sanofi Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 73. Sanofi Influenza Vaccine Product

    Table 74. Sanofi Recent Developments/Updates

    Table 75. CSL Corporation Information

    Table 76. CSL Description and Business Overview

    Table 77. CSL Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 78. CSL Influenza Vaccine Product

    Table 79. CSL Recent Developments/Updates

    Table 80. GSK Corporation Information

    Table 81. GSK Description and Business Overview

    Table 82. GSK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 83. GSK Influenza Vaccine Product

    Table 84. GSK Recent Developments/Updates

    Table 85. Viatris Corporation Information

    Table 86. Viatris Description and Business Overview

    Table 87. Viatris Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 88. Viatris Influenza Vaccine Product

    Table 89. Viatris Recent Developments/Updates

    Table 90. AstraZeneca Corporation Information

    Table 91. AstraZeneca Description and Business Overview

    Table 92. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 93. AstraZeneca Influenza Vaccine Product

    Table 94. AstraZeneca Recent Developments/Updates

    Table 95. Hualan Bio Corporation Information

    Table 96. Hualan Bio Description and Business Overview

    Table 97. Hualan Bio Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 98. Hualan Bio Influenza Vaccine Product

    Table 99. Hualan Bio Recent Developments/Updates

    Table 100. Changchun Institute of Biological Corporation Information

    Table 101. Changchun Institute of Biological Description and Business Overview

    Table 102. Changchun Institute of Biological Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 103. Changchun Institute of Biological Influenza Vaccine Product

    Table 104. Changchun Institute of Biological Recent Developments/Updates

    Table 105. Sinovac Corporation Information

    Table 106. Sinovac Description and Business Overview

    Table 107. Sinovac Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 108. Sinovac Influenza Vaccine Product

    Table 109. Sinovac Recent Developments/Updates

    Table 110. BCHT Corporation Information

    Table 111. BCHT Description and Business Overview

    Table 112. BCHT Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 113. BCHT Influenza Vaccine Product

    Table 114. BCHT Recent Developments/Updates

    Table 115. Jiangsu GDK Corporation Information

    Table 116. Jiangsu GDK Description and Business Overview

    Table 117. Jiangsu GDK Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 118. Jiangsu GDK Influenza Vaccine Product

    Table 119. Jiangsu GDK Recent Developments/Updates

    Table 120. KM Biologics Corporation Information

    Table 121. KM Biologics Description and Business Overview

    Table 122. KM Biologics Influenza Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2018-2023)

    Table 123. KM Biologics Influenza Vaccine Product

    Table 124. KM Biologics Recent Developments/Updates

    Table 125. Key Raw Materials Lists

    Table 126. Raw Materials Key Suppliers Lists

    Table 127. Influenza Vaccine Distributors List

    Table 128. Influenza Vaccine Customers List

    Table 129. Influenza Vaccine Market Trends

    Table 130. Influenza Vaccine Market Drivers

    Table 131. Influenza Vaccine Market Challenges

    Table 132. Influenza Vaccine Market Restraints

    Table 133. Research Programs/Design for This Report

    Table 134. Key Data Information from Secondary Sources

    Table 135. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Influenza Vaccine

    Figure 2. Global Influenza Vaccine Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Influenza Vaccine Market Share by Type in 2022 & 2029

    Figure 4. Trivalent Influenza Vaccine Product Picture

    Figure 5. Quadrivalent Influenza Vaccine Product Picture

    Figure 6. Global Influenza Vaccine Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 7. Global Influenza Vaccine Market Share by Application in 2022 & 2029

    Figure 8. 6 Months to 3 Years

    Figure 9. > 3 Years

    Figure 10. Global Influenza Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 11. Global Influenza Vaccine Market Size (2018-2029) & (US$ Million)

    Figure 12. Global Influenza Vaccine Sales (2018-2029) & (M Doses)

    Figure 13. Global Influenza Vaccine Average Price (USD/Doses) & (2018-2029)

    Figure 14. Influenza Vaccine Report Years Considered

    Figure 15. Influenza Vaccine Sales Share by Manufacturers in 2022

    Figure 16. Global Influenza Vaccine Revenue Share by Manufacturers in 2022

    Figure 17. The Global 5 and 10 Largest Influenza Vaccine Players: Market Share by Revenue in 2022

    Figure 18. Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 19. Global Influenza Vaccine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 20. North America Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 21. North America Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 22. U.S. Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 23. Canada Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 24. Europe Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 25. Europe Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 26. Germany Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. France Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. U.K. Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Italy Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. Russia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. Asia Pacific Influenza Vaccine Sales Market Share by Region (2018-2029)

    Figure 32. Asia Pacific Influenza Vaccine Revenue Market Share by Region (2018-2029)

    Figure 33. China Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Japan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. South Korea Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. India Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Australia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. China Taiwan Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Indonesia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Thailand Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. Malaysia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Latin America Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 43. Latin America Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 44. Mexico Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Brazil Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Argentina Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Middle East & Africa Influenza Vaccine Sales Market Share by Country (2018-2029)

    Figure 48. Middle East & Africa Influenza Vaccine Revenue Market Share by Country (2018-2029)

    Figure 49. Turkey Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Saudi Arabia Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. UAE Influenza Vaccine Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Global Sales Market Share of Influenza Vaccine by Type (2018-2029)

    Figure 53. Global Revenue Market Share of Influenza Vaccine by Type (2018-2029)

    Figure 54. Global Influenza Vaccine Price (USD/Doses) by Type (2018-2029)

    Figure 55. Global Sales Market Share of Influenza Vaccine by Application (2018-2029)

    Figure 56. Global Revenue Market Share of Influenza Vaccine by Application (2018-2029)

    Figure 57. Global Influenza Vaccine Price (USD/Doses) by Application (2018-2029)

    Figure 58. Influenza Vaccine Value Chain

    Figure 59. Influenza Vaccine Production Process

    Figure 60. Channels of Distribution (Direct Vs Distribution)

    Figure 61. Distributors Profiles

    Figure 62. Bottom-up and Top-down Approaches for This Report

    Figure 63. Data Triangulation

    Figure 64. Key Executives Interviewed